No.

Publication Date

Citing Article

1

2023

Alba Rojano, Elena Sena, Ramiro Manzano-Nuñez, Juan M. Pericàs, Andreea Ciudin. NAFLD as the metabolic hallmark of obesity, Internal and Emergency Medicine. 2023; 18: 31.  https://doi.org/10.1007/s11739-022-03139-x

2

2025

Silvio Pires Gomes, Gabriela Salim de Castro, Vinicius Pedro Silva de Oliveira, Bruno Cogliati, Andressa Galvão da Silva Iacopino, Ivanir Santana de Oliveira Pires, Bruno Cesar Schimming, Fernanda Gosuen Gonçalves Dias, José Roberto Kfoury Junior, Tais Harumi de Castro Sasahara. Hepatic stereological analysis in obese Zucker rats (Leprfa) with dyslipidemia, Acta Cirúrgica Brasileira. 2025; 40: e402325.  https://doi.org/10.1590/acb402325

3

2021

Yu‐Ling Sun, Tao Bai, Lin Zhou, Rong‐Tao Zhu, Wei‐Jie Wang, Ruo‐Peng Liang, Jian Li, Chi‐Xian Zhang, Jian‐Jun Gou. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial–mesenchymal transition, Journal of Cellular Physiology. 2021; 236: 4313.  https://doi.org/10.1002/jcp.30174

4

2023

Li-Li Ren, Xiao-Jun Li, Ting-Ting Duan, Zheng-Hai Li, Jun-Zheng Yang, Ya-Mei Zhang, Liang Zou, Hua Miao, Ying-Yong Zhao. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities, Chemico-Biological Interactions. 2023; 369: 110289110289.  https://doi.org/10.1016/j.cbi.2022.110289

5

2021

Csaba Adori, Teresa Daraio, Raoul Kuiper, Swapnali Barde, Lubica Horvathova, Takashi Yoshitake, Robert Ihnatko, Ismael Valladolid-Acebes, Pauline Vercruysse, Ashley M. Wellendorf, Roberto Gramignoli, Bela Bozoky, Jan Kehr, Elvar Theodorsson, Jose A. Cancelas, Boris Mravec, Carl Jorns, Ewa Ellis, Jan Mulder, Mathias Uhlén, Christina Bark, Tomas Hökfelt. Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging, Science Advances. 2021; 7: eabg5733.  https://doi.org/10.1126/sciadv.abg5733

6

2022

Joseph Crutison, Thomas Royston. The design and application of a diffusion tensor informed finite-element model for exploration of uniaxially prestressed muscle architecture in magnetic resonance imaging, Engineering with Computers. 2022; 38: 3893.  https://doi.org/10.1007/s00366-022-01690-x

7

2022

Dan Su, Jian Luo, Junqi Ge, Yali Liu, Chen Jin, Pengfei Xu, Ruowen Zhang, Genhua Zhu, Ming Yang, Zhifu Ai, Yonggui Song. Raw and Wine Processed Schisandra chinensis Regulate NREM-Sleep and Alleviate Cardiovascular Dysfunction Associated with Insomnia by Modulating HPA Axis, Planta Medica. 2022; 88: 1311.  https://doi.org/10.1055/a-1721-4971

8

2024

Gyorgy Baffy, Piero Portincasa. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective, Metabolites. 2024; 14: 324.  https://doi.org/10.3390/metabo14060324

9

2025

Rui Zuo, Mi Wang, Yun-Ting Wang, YangPing ShenTu, Alexandra K. Moura, Ying Zhou, Kiana Roudbari, Jenny Z. Hu, Pin-Lan Li, JiuKuan Hao, Xiang Li, Yang Zhang. Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Nonalcoholic Steatohepatitis in Mice, The American Journal of Pathology. 2025; 195: 542.  https://doi.org/10.1016/j.ajpath.2024.11.003

10

2021

Miren Bravo, Imma Raurell, Aurora Barberá, Diana Hide, Mar Gil, Federico Estrella, María Teresa Salcedo, Salvador Augustin, Joan Genescà, María Martell. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH, Disease Models & Mechanisms. 2021; 14: dmm048884.  https://doi.org/10.1242/dmm.048884

11

2022

Michal Sýkora, Kateřina Cimburová. Pathological changes of a spleen and prevention of infectious complications in asplenic patients, Medicína pro praxi. 2022; 19: 202.  https://doi.org/10.36290/med.2022.032

12

2023

Monika Adori, Sadam Bhat, Roberto Gramignoli, Ismael Valladolid-Acebes, Tore Bengtsson, Mathias Uhlèn, Csaba Adori. Hepatic Innervations and Nonalcoholic Fatty Liver Disease, Seminars in Liver Disease. 2023; 43: 149.  https://doi.org/10.1055/s-0043-57237

13

2023

Raymond A. Isidro, Lei Zhao. Evolving Understanding of Noncirrhotic Portal Hypertension, Surgical Pathology Clinics. 2023; 16: 549.  https://doi.org/10.1016/j.path.2023.04.009

14

2023

Stan Bukofzer, Geoffrey Harris, Susan Song, Edward E Cable. OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension, Journal of Experimental Pharmacology. 2023; Volume 15: 279.  https://doi.org/10.2147/JEP.S416673

15

2023

Eric Felli, Sonia Selicean, Sergi Guixé-Muntet, Cong Wang, Jaume Bosch, Annalisa Berzigotti, Jordi Gracia-Sancho. Mechanobiology of portal hypertension, JHEP Reports. 2023; 5: 100869100869.  https://doi.org/10.1016/j.jhepr.2023.100869

16

2024

Anita Madir, Ivica Grgurevic, Emmanuel A Tsochatzis, Massimo Pinzani. Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges, World Journal of Gastroenterology. 2024; 30: 290.  https://doi.org/10.3748/wjg.v30.i4.290

17

2024

Emma Hajaj, Ahinoam Glusman Bendersky, Marius Braun, Amir Shlomai. 2024;   https://doi.org/10.1101/2024.10.26.24316188

18

2022

Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications, International Journal of Molecular Sciences. 2022; 23: 13320.  https://doi.org/10.3390/ijms232113320

19

2022

Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. 2022; 475.  https://doi.org/10.1016/B978-0-12-819265-8.00079-6

20

2021

Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment, European Medical Journal. 2021; 80.  https://doi.org/10.33590/emj/21-00039

21

2025

О. Ю. Фофанова, В. В. Феденько, З. Я. Гурик, Е. О. Кіндратів, І. Г. Лаб'як. КЛІНІКО-МОРФОЛОГІЧНІ АСПЕКТИ ПЕРВИННОГО НЕАЛКОГОЛЬНОГО СТЕАТОГЕПАТИТУ ЗА НАЯВНОСТІ КОМОРБІДНОЇ ПАТОЛОГІЇ ЖОВЧНОГО МІХУРА, Art of Medicine. 2025; 113.  https://doi.org/10.21802/artm.2025.2.34.113

22

2021

Véronique V. van Cooten, Daan J. de Jong, Frank J. Wessels, Pim A. de Jong, Madeleine Kok. Liver Enhancement on Computed Tomography Is Suboptimal in Patients with Liver Steatosis, Journal of Personalized Medicine. 2021; 11: 1255.  https://doi.org/10.3390/jpm11121255

23

2021

Guido Costa, Lara Cavinato, Chiara Masci, Francesco Fiz, Martina Sollini, Letterio Salvatore Politi, Arturo Chiti, Luca Balzarini, Alessio Aghemo, Luca di Tommaso, Francesca Ieva, Guido Torzilli, Luca Viganò. Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases, Cancers. 2021; 13: 3077.  https://doi.org/10.3390/cancers13123077

24

2025

María Andrés-Rozas, Zoe Boyer-Diaz, Eugènia Ruiz-Cánovas, Peio Aristu-Zabalza, Sergi Guixé-Muntet, Cristina Fernández-Asensio, Juan José Lozano, Noemí García-Delgado, Carla Fuster, Jaume Mercade, Jaime Bosch, Jordi Gracia-Sancho. GTX-11 IMPROVES PORTAL HYPERTENSION, LIVER FIBROSIS AND SINUSOIDAL CELLS PHENOTYPE IN EXPERIMENTAL MASH, JHEP Reports. 2025; 101497101497.  https://doi.org/10.1016/j.jhepr.2025.101497

25

2023

Joy Ito, Hector Lemus, Tianying Wu. Serum Phosphorus, Serum Bicarbonate, and Renal Function in Relation to Liver CYP1A2 Activity, Diagnostics. 2023; 13: 2996.  https://doi.org/10.3390/diagnostics13182996

26

2024

Eden Hornung, Sirisha Achanta, Alison Moss, James S. Schwaber, Rajanikanth Vadigepalli, Tomohiko Ai. Multi-organ gene expression analysis and network modeling reveal regulatory control cascades during the development of hypertension in female spontaneously hypertensive rat, PLOS ONE. 2024; 19: e0313252.  https://doi.org/10.1371/journal.pone.0313252

27

2022

Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients, Current Oncology Reports. 2022; 24: 1461.  https://doi.org/10.1007/s11912-022-01319-8

28

2023

Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu. The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study, European Journal of Gastroenterology & Hepatology. 2023; 35: 889.  https://doi.org/10.1097/MEG.0000000000002583

29

2024

William S. Reiche, Ryan W. Walters, Bryce F. Schutte, Sandeep Mukherjee, Haitam M. Buaisha. Mild Thrombocytopenia, a Predictor of Outcomes After Laparoscopic Cholecystectomy, Journal of Clinical Gastroenterology. 2024; 58: 507.  https://doi.org/10.1097/MCG.0000000000001926

30

2023

Matteo Boninsegna, Peter A. G. McCourt, Christopher Florian Holte. The Computed Sinusoid, Livers. 2023; 3: 657.  https://doi.org/10.3390/livers3040043

31

2023

Piero Portincasa, NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care, Internal and Emergency Medicine. 2023; 18: 993.  https://doi.org/10.1007/s11739-023-03203-0